Abbott Laboratories (NYSE:ABT) is included among the 10 Oversold Dividend Stocks to Buy According to Hedge Funds. The company reported strong earnings in the second quarter of 2025. It posted revenue ...

We came across a bullish thesis on Abbott Laboratories on r/ValueInvesting subreddit by anonymous_sheep1. In this article, we ...

Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...

"Halfway through the year, we delivered high single-digit organic sales growth, double-digit EPS growth, significantly ...

Abbott Laboratories (NYSE:ABT) stock drops as the company reported mixed Q2 2025 results and sets its Q3 guidance below ...

Abbott Laboratories CEO Robert Ford unpacked his company’s latest quarterly report in a Thursday interview with CNBC’s Jim ...

Abbott Laboratories (NYSE:ABT) reported better-than-expected sales and profits in the second quarter, but the stock still ...

Over the past few years, Abbott Laboratories' (ABT 2.65%) business has been a bit of a roller coaster. The pandemic disrupted its medical device business, but it was later able to smooth out those ...

Abbott Laboratories is also an excellent dividend stock, currently on a streak of 52 consecutive payout increases. If you opt to reinvest the dividend -- currently yielding 1.8% ...

Abbott Laboratories chief executive said the company has “shipped over 1 billion tests since the start of the pandemic.” Sales of diagnostic tests for Covid-19 have been a huge profit and ...